Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Vascular Biogenics Ltd (VBLT) PT Raised to $25 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades NICE Systems Ltd (NICE) to Neutral Citing Valuation
-
Benefitfocus (BNFT) PT Lowered to $28 at Chardan Capital Markets on 3Q Report; 'Management Sounded Cautious About Outlook for Topline in 2018'
-
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million
-
uniQure Announces Closing of its Public Offering
-
Social Reality (SRAX) Reports $5.18M Private Placement with Existing Shareholders
-
SRAX Announces Private Placement of $5.18 Million with Existing Shareholders
-
uniQure (QURE) Prices 5M Share Common Offering at $18.25/Sh
-
uniQure Announces Pricing of its Public Offering
-
uniQure (QURE) to Offer 5M Shares
-
uniQure Announces Proposed Public Offering
-
Pre-Open Stock Movers 10/20: (SKX) (TEAM) (QURE) Higher; (DRRX) (NCR) (CELG) (GE) Lower (more...)
-
After-Hours Stock Movers 10/19: (SKX) (TEAM) (IMPV) (PYPL) Higher; (NCR) (CELG) (ATHN) Lower (more...)
-
uniQure BV (QURE) PT Raised 180% to $35 at Chardan Capital Markets; Sees Heb B Leadership in GT
-
Asterias Biotherapeutics Announces Closing of $10.4 Million Registered Direct Offering
-
Black Ridge Acquisition Corp. Announces Closing Of Over-Allotment Option With Respect To Initial Public Offering
-
Black Ridge Oil & Gas, Inc. Announces Closing of SPAC Over-allotment Related to Initial Public Offering
-
FBR Capital Markets & Co.’s Senior Equity Research Healthcare Analyst Madhu Kumar, Ph.D. Named to Institutional Investor’s 2017 All-America Research Team Rising Stars List
-
BioTime, Inc. Announces Closing of Public Offering and Underwriters’ Full Exercise of Over-Allotment Option
-
Social Reality (SRAX) to Explore Strategic Alternatives for SRAXmd Healthcare Business
-
Social Reality, Inc. to Pursue Strategic Alternatives for SRAXmd Healthcare Business
-
Pre-Open Stock Movers 10/16: (TRXC) (RT) (EXEL) Higher; (AMPE) (ADBE) (ISRG) Lower (more...)
-
Asterias Biotherapeutics Announces $10.4 Million Registered Direct Offering
-
NICE Systems Ltd (NICE) PT Raised to $91 at Chardan Capital Markets
-
22nd Century Group (XXII) PT Raised to $11.50 at Chardan Capital Markets; a Solution to Big Tobacco's $30B Problem
-
BioTime (BTX) Prices 9.6M Share Common Offering at $2.60/Sh
-
BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock
-
Globalstar (GSAT) Equity Raise Positions it to Focus on Spectrum Monetization - Chardan Capital Markets
-
Globalstar Announces Completion of Public Offering of Voting Common Stock
-
22nd Century Group Closes $54 Million Common Stock Only Registered Direct Offering
-
PlacementTracker Publishes Q3 2017 Private Placement Market League Tables
-
Black Ridge Oil & Gas, Inc. Announces Closing of SPAC Initial Public Offering
-
Black Ridge Acquisition Corp. Announces Closing Of Initial Public Offering
-
Arbutus to Participate in Upcoming Investor Conferences
-
22nd Century Group (XXII) Reports $54M Registered Direct Offering of Common Stock
-
22nd Century Group Announces $54 Million Common Stock Only Registered Direct Offering
-
bluebird bio to Present at Chardan Gene Therapy Conference
-
Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference
-
ProQR to Present at the Chardan Inaugural Gene Therapy Conference
-
GlobalStar (GSAT) Prices 73.356M Shares Common Offering at $1.65/Sh
-
Globalstar Announces Pricing of Public Offering of Voting Common Stock
-
Black Ridge Oil & Gas, Inc. Announces Pricing of SPAC Initial Public Offering
-
Axovant Sciences (AXON): Still Bearish - Chardan
-
Black Ridge Acquisition Corp. (BRAC) Prices 12M Share IPO at $10/Sh
-
Black Ridge Acquisition Corp. Announces Pricing of Initial Public Offering
-
CRISPR Therapeutics to Present at Investor Conferences in October
-
Lysogene Announces Company Presentations at October & November Investor Conferences
-
Amicus Therapeutics (FOLD) PT Raised to $18.50 at Chardan Capital Markets
-
Lysogene Announces Company Presentations at October & November Investor Conferences
-
GenSight Biologics to Attend Chardan Gene Therapy Conference

